Apotex Seeks Approval For Generic Ulcer Medication
Apotex filed a complaint for declaratory judgment on Wednesday, asking the court to declare that its generic version of Zantac Syrup does not infringe Glaxo’s patent.
Apotex has already submitted and certified an Abbreviated New Drug Application for its drug, generically known as ranitidine hydrocholoride, to the U.S. Food and Drug Administration. Apotex said it has...
To view the full article, register now.